10/24/24 17:04 | 10/22/24 | TECX | Health | BioPrd | Biological Products, (No Diag | Springer Timothy A | MA | DT | | P | 10,077 | 33.59 | 0 | 300 | 7 | 4,593 | D | | | | | | | | | | | | | | |
9/26/24 18:15 | 9/26/24 | TECX | Health | BioPrd | Biological Products, (No Diag | Springer Timothy A | MA | DT | | P | 1,441 | 28.82 | 0 | 50 | 1 | 4,293 | M | | | | | | | | | | | | | | |
5/15/24 11:21 | 5/13/24 | AVRO | Health | BioPrd | Biological Products, (No Diag | Leonard Braden Michael | IN | T | | P.m | 971 | 1.27 | 0 | 767 | 17 | 5,168 | I | | | | | | | | | | | | | | |
2/5/24 20:01 | 2/1/24 | AVRO | Health | BioPrd | Biological Products, (No Diag | Golipour Azadeh | MA | O | CTO | M.d | 0 | 0.00 | 0 | 37 | 201 | 56 | D | | | | | | | | | | | | | | |
2/5/24 19:59 | 2/1/24 | AVRO | Health | BioPrd | Biological Products, (No Diag | Ridha Essra | MA | O | Chief Me | M.d | 0 | 0.00 | 0 | 33 | | 16 | D | | | | | | | | | | | | | | |
2/5/24 19:57 | 2/1/24 | AVRO | Health | BioPrd | Biological Products, (No Diag | Ostrowski Erik | MA | O | Interim | M.d | 0 | 0.00 | 0 | 40 | | 29 | D | | | | | | | | | | | | | | |
2/5/24 19:56 | 2/1/24 | AVRO | Health | BioPrd | Biological Products, (No Diag | Avruch Steven | MA | O | GC | M.d | 0 | 0.00 | 0 | 33 | | 22 | D | | | | | | | | | | | | | | |
1/26/23 17:30 | 1/24/23 | AVRO | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | P,CEO | M.d | 42 | 0.9100 | 0 | 46 | 6 | 778 | M | | | | | | | | | | | | | | |
12/28/22 19:18 | 12/23/22 | AVRO | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | P,CEO | M.d | 59 | 0.4132 | 0 | 142 | 24 | 732 | D | | | | | | | | | | | | | | |
7/8/21 16:21 | 7/7/21 | AVRO | Health | BioPrd | Biological Products, (No Diag | Vickers Philip J. | MA | D | | P | 40 | 8.35 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
2/18/21 19:06 | 2/17/21 | AVRO | Health | BioPrd | Biological Products, (No Diag | Donenberg Phillip B. | MA | D | | P | 23 | 11.71 | 0 | 2 | New | 2 | D | | | | | | | | | | | | | | |
12/28/20 19:46 | 12/24/20 | AVRO | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | P,CEO | M.d | 41 | 0.4132 | 0 | 100 | 20 | 590 | D | | | | | | | | | | | | | | |
2/14/20 19:16 | 2/12/20 | AVRO | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | See Rema | S | -41 | 29.07 | 0 | -1 | 0 | 490 | D | | | | | | | | | | | | | | |
2/11/20 21:26 | 2/11/20 | AVRO | Health | BioPrd | Biological Products, (No Diag | Paige Christopher | MA | D | | S | -420 | 28.00 | 0 | -15 | -6 | 253 | D | | | | | | | | | | | | | | |
2/11/20 21:23 | 2/11/20 | AVRO | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | See Rema | S | -1,737 | 27.57 | 0 | -63 | -11 | 492 | D | | | | | | | | | | | | | | |
1/30/20 16:10 | 1/28/20 | AVRO | Health | BioPrd | Biological Products, (No Diag | Paige Christopher | MA | D | | S | -230 | 23.00 | 0 | -10 | -4 | 268 | D | | | | | | | | | | | | | | |
7/23/19 16:09 | 7/19/19 | AVRO | Health | BioPrd | Biological Products, (No Diag | Atlas Venture Fund X, L.P. | MA | T | | P | 15,000 | 18.50 | 0 | 811 | 17 | 5,567 | I | | | | | | | | | | | | | | |
7/23/19 16:09 | 7/19/19 | AVRO | Health | BioPrd | Biological Products, (No Diag | Booth Bruce | MA | D | | P | 15,000 | 18.50 | 0 | 811 | 17 | 5,567 | I | | | | | | | | | | | | | | |
4/9/19 16:39 | 4/5/19 | AVRO | Health | BioPrd | Biological Products, (No Diag | Paige Christopher | MA | D | | S.m | -257 | 25.72 | 0 | -10 | -3 | 278 | D | | | | | | | | | | | | | | |
4/9/19 16:27 | 4/5/19 | AVRO | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | See Rema | S.m | -382 | 27.25 | 0 | -14 | -2 | 555 | D | | | | | | | | | | | | | | |
10/10/18 18:11 | 10/8/18 | AVRO | Health | BioPrd | Biological Products, (No Diag | Dorton Katina | MA | O | CFO | M.d | 9 | 0.9100 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
10/10/18 18:05 | 10/8/18 | AVRO | Health | BioPrd | Biological Products, (No Diag | Kreher Nerissa | MA | O | Chief Me | M.d | 3 | 0.9100 | 0 | 3 | New | 3 | D | | | | | | | | | | | | | | |